PolarCool AB Stock

Equities

POLAR

SE0012570422

Biotechnology & Medical Research

End-of-day quote NORDIC GROWTH MARKET 5-day change 1st Jan Change
- SEK -.--% Intraday chart for PolarCool AB -.--% -.--%
Sales 2021 0.75 7.91 Sales 2022 1.9 20.18 Capitalization 551K 5.84M
Net income 2021 -7M -74.19M Net income 2022 -12M -127M EV / Sales 2021 * -
Net cash position 2021 * - 0 Net cash position 2022 * - 0 EV / Sales 2022 * -
P/E ratio 2021 *
-
P/E ratio 2022 *
-
Employees 3
Yield 2021 *
-
Yield 2022 *
-
Free-Float 99%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer 42 -
Comptroller/Controller/Auditor 28 -
Sales & Marketing 33 -
Members of the board TitleAgeSince
Chairman - 19-12-31
Director/Board Member 77 17-12-31
Director/Board Member 77 19-12-31
More insiders
Polarcool AB is a Sweden-based medical device company specializing in sports medicine. The Company focuses on of concussive and sub-concussive brain injuries. It develops a portable brain cooling device called PolarCap System. The PolarCap System consists of a cooling unit and a silicone-based cooling cap alongside neoprene insulation, cooling the head and neck via a circulating coolant during a procedure that takes approximately 45-60 minutes. The idea behind it is the reduction of brain temperature of individuals suffering from a concussion or participating in an activity where repetitive head impact occurs, such as contact and combat sports, in order to prevent or limit long term cognitive impairment. The device undergoes preclinical cohort study for concussion among hockey players and a preclinical study for indication of sub-concussive repetitive head impact among American football players.
More about the company